Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
VRDN
VRDN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
VRDN News
HighVista Strategies Reduces Stake in Viridian Therapeutics
May 17 2026
Fool
HighVista Strategies Cuts Stake in Viridian Therapeutics by $7 Million
May 17 2026
Yahoo Finance
Viridian Therapeutics Raises $350M Through Upsized Public Offerings
May 07 2026
seekingalpha
Viridian Therapeutics Completes $225 Million Financing
May 07 2026
Newsfilter
Viridian Therapeutics Reveals Pricing for Increased Concurrent Public Offerings of 1.75% Convertible Senior Notes Due 2032 and Common Stock, Targeting Total Gross Proceeds of $350 Million
May 07 2026
moomoo
Viridian Therapeutics Stock Soars 33.36% Amid Treatment Launch
May 06 2026
Yahoo Finance
Viridian's Therapy Shows Strong Results, Stock Surges
May 05 2026
stocktwits
Kopp Family Office Reduces Stake in Viridian Therapeutics
Apr 21 2026
Fool
Viridian Reveals Partnership Agreement with Outside the Box Capital for Market Services
Apr 15 2026
moomoo
Surge in Options Trading Volume for OraSure and Viridian
Apr 06 2026
NASDAQ.COM
Amgen's Phase 3 Trial Success Leads to Viridian Stock Plunge
Apr 06 2026
stocktwits
Viridian Therapeutics Shares Plummet: The Connection to an Amgen Study Explained.
Apr 06 2026
Barron's
Stock Movers: Seagate, Micron, Tesla, Kratos, Strategy, Soleno, Viridian, and Others
Apr 06 2026
Barron's
Biotech Landscape Update: Regulatory Approvals and Acquisitions
Apr 03 2026
NASDAQ.COM
Immunovant Reports Disappointing Trial Results, Shares Drop
Apr 02 2026
stocktwits
Mixed Close for US Stocks as Nasdaq Hits 7.75-Month Low Amid Middle East Tensions
Mar 30 2026
NASDAQ.COM
Show More News
